Literature DB >> 19414767

Autoreactive anti-DNA transgenic B cells in lupus-prone New Zealand black/New Zealand white mice show near perfect L chain allelic exclusion.

Efi Makdasi1, Ruth Fischel, Inbal Kat, Dan Eilat.   

Abstract

Recent work on B cell tolerance and autoimmunity has suggested the L chain allelic inclusion is a property of autoreactive B cells and is closely linked to receptor editing. Allelic inclusion could rescue autoreactive B cells from clonal deletion by reducing their effective BCR surface density. We have investigated this phenomenon in anti-DNA producing hybridomas, derived from different strains of Ig gene-targeted, lupus-prone NZB/NZW mice. Our results indicate that isotype and allelic exclusion was strictly maintained in most high- and low-affinity, edited and nonedited, anti-DNA transgenic B cells. However, a substantial fraction of the anti-DNA hybridomas expressed a very restricted set of nonproductively rearranged L chain mRNA, in addition to the productive anti-DNA L chain. The aberrant L chains could have a role in the selection and survival of autoreactive B cells in these autoimmune mice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19414767     DOI: 10.4049/jimmunol.0803610

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

Review 1.  B cell receptor editing in tolerance and autoimmunity.

Authors:  Eline T Luning Prak; Marc Monestier; Robert A Eisenberg
Journal:  Ann N Y Acad Sci       Date:  2011-01-05       Impact factor: 5.691

2.  Autoantibodies: Focus on anti-DNA antibodies.

Authors:  Nina Almqvist; Thomas H Winkler; Inga-Lill Mårtensson
Journal:  Self Nonself       Date:  2011-01-01

3.  1(st) French-Israeli International Conference on B Cells and therapeutic antibodies: October 23-25, 2011 Jerusalem, Israel.

Authors:  Claude-Agnès Reynaud; Sandrine Moutel; Marie-Caroline Dieu-Nosjean; Reuven Laskov; Jean-Luc Teillaud
Journal:  MAbs       Date:  2012-07-01       Impact factor: 5.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.